PathAIAI-powered pathology platform for precision diagnostics and biomarker discovery.

Our company's mission is to improve patient outcomes with reliable AI-powered technology and meaningful collaboration. We achieve this by providing invaluable insights for biomarker discovery and drug development, and by improving laboratory workflows. At PathAI, we offer an AI-powered pathology platform for precision diagnostics and biomarker discovery. This platform includes a cloud-native, open platform enterprise workflow solution, AISight, which serves as a central hub for case management, image management, and best-in-class artificial intelligence tools. This solution enables multiple histopathology use cases, such as case management, image management, and AI applications. We have a proprietary pathologist contributor network of 450+ board-certified pathologists, who have contributed 32.5 million annotations to aid in the training and validation of our AI-based algorithms. Our technology is used by leading laboratories and research centers to power their digital pathology workflows and AI applications. Our company has partnered with various organizations, including MedStar Health and Labcorp, to deploy our digital pathology platform and advanced AI applications. We have also received FDA clearance for our AISight Dx platform for primary diagnosis. PathAI is a leading company in AI-powered pathology, and we are committed to advancing precision medicine by leveraging the power of artificial intelligence. Our team is passionate about solving big challenges in healthcare and transforming the field of pathology with artificial intelligence.